Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1950 1
1954 2
1955 2
1957 1
1958 2
1959 1
1962 1
1963 2
1966 1
1967 1
1969 3
1970 2
1971 1
1972 2
1973 4
1974 5
1975 5
1976 2
1977 3
1978 2
1979 5
1980 5
1981 6
1982 10
1983 4
1984 3
1985 12
1986 2
1987 4
1988 4
1989 3
1990 6
1991 9
1992 7
1993 7
1994 9
1995 10
1996 11
1997 8
1998 12
1999 14
2000 11
2001 9
2002 13
2003 10
2004 13
2005 12
2006 7
2007 13
2008 19
2009 13
2010 12
2011 22
2012 13
2013 16
2014 22
2015 12
2016 12
2017 19
2018 18
2019 12
2020 16
2021 11
2022 14
2023 24
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

510 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for leukemia AND Vitamin C
Search for leucemia AND Vitamin C instead (1 results)
Vitamin C and D supplementation in acute myeloid leukemia.
Mouchel PL, Bérard E, Tavitian S, Gadaud N, Vergez F, Rieu JB, Luquet I, Sarry A, Huguet F, Largeaud L, Delabesse E, Huynh A, Bertoli S, Récher C. Mouchel PL, et al. Blood Adv. 2023 Nov 28;7(22):6886-6897. doi: 10.1182/bloodadvances.2023010559. Blood Adv. 2023. PMID: 37671973 Free PMC article.
Recent studies have highlighted the role of vitamin C and D in acute myeloid leukemia (AML). In 2018, we changed our practices to add both vitamins to the supportive care for all consecutive patients with AML undergoing intensive chemotherapy. ...Most patient …
Recent studies have highlighted the role of vitamin C and D in acute myeloid leukemia (AML). In 2018, we changed our pr …
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, Grillo I, Bakogianni S, Ndiaye-Lobry D, Martín MT, Guillamot M, Banh RS, Xu M, Figueroa ME, Dickins RA, Abdel-Wahab O, Park CY, Tsirigos A, Neel BG, Aifantis I. Cimmino L, et al. Cell. 2017 Sep 7;170(6):1079-1095.e20. doi: 10.1016/j.cell.2017.07.032. Epub 2017 Aug 17. Cell. 2017. PMID: 28823558 Free PMC article.
Vitamin C also drives DNA hypomethylation and expression of a TET2-dependent gene signature in human leukemia cell lines. Furthermore, TET-mediated DNA oxidation induced by vitamin C treatment in leukemia cells enhances their sensitivity
Vitamin C also drives DNA hypomethylation and expression of a TET2-dependent gene signature in human leukemia cell line
Functional benefit and molecular mechanism of vitamin C against perfluorooctanesulfonate-associated leukemia.
Li R, Guo C, Li Y, Liang X, Su M. Li R, et al. Chemosphere. 2021 Jan;263:128242. doi: 10.1016/j.chemosphere.2020.128242. Epub 2020 Sep 4. Chemosphere. 2021. PMID: 33297189
Perfluorooctanesulfonate (PFOS) is a persistent pollutant that can induce toxic effects, including leukemia, on blood cells. Vitamin C (VC), a functional nutrient, has been found to possess potent cytoprotective effects. ...According to the computational find …
Perfluorooctanesulfonate (PFOS) is a persistent pollutant that can induce toxic effects, including leukemia, on blood cells. Vitam
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia.
Ottone T, Faraoni I, Fucci G, Divona M, Travaglini S, De Bellis E, Marchesi F, Angelini DF, Palmieri R, Gurnari C, Giansanti M, Nardozza AM, Montesano F, Fabiani E, Lindfors Rossi EL, Cerretti R, Cicconi L, De Bardi M, Catanoso ML, Battistini L, Massoud R, Venditti A, Voso MT. Ottone T, et al. Front Oncol. 2022 Jun 27;12:890344. doi: 10.3389/fonc.2022.890344. eCollection 2022. Front Oncol. 2022. PMID: 35832559 Free PMC article.
Vitamin C has been shown to play a significant role in suppressing progression of leukemia through epigenetic mechanisms. We aimed to study the role of vitamin C in acute myeloid leukemia (AML) biology and clinical course. ...
Vitamin C has been shown to play a significant role in suppressing progression of leukemia through epigenetic mechanism
Association of Leukemia Target Genes Tet2, Bcl2, and Slc23a2 in Vitamin C Pathways.
Li J, Zhang W, Liu W, Rong J, Chen Y, Gu W, Zhang W. Li J, et al. Cancer Genomics Proteomics. 2019 Sep-Oct;16(5):333-344. doi: 10.21873/cgp.20138. Cancer Genomics Proteomics. 2019. PMID: 31467227 Free PMC article.
BACKGROUND: Vitamin C has been used in combination with several target genes in the treatment of leukemia. ...In conclusion, Alternative pathways and key genes that connect Tet2, Bcl2, and Slc23a2 for their therapeutic applications with vitamin C
BACKGROUND: Vitamin C has been used in combination with several target genes in the treatment of leukemia. ...In conclu …
Vitamin C promotes anti-leukemia of DZNep in acute myeloid leukemia.
Long B, Shan Y, Sun Y, Wang T, Li X, Huang K, Zhang W, He Y, Wen R, Li Y, Mai Y, Feng Y, Zhang T, Kang B, Zhang C, Zhu Y, Gu J, Liu J, Zhang X, Pan G. Long B, et al. Biochim Biophys Acta Mol Basis Dis. 2022 May 1;1868(5):166357. doi: 10.1016/j.bbadis.2022.166357. Epub 2022 Feb 7. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 35143932 Free article.
The epigenetic treatment by 3-Deazaneplanocin A (DZNep), a histone methyltransferase inhibitor, shows great potential against acute myeloid leukemia (AML). However, the variant sensitivity and incomplete response to DZNep are commonly observed. Here, we reveal that vita
The epigenetic treatment by 3-Deazaneplanocin A (DZNep), a histone methyltransferase inhibitor, shows great potential against acute myeloid …
Vitamin C - A new player in regulation of the cancer epigenome.
Gillberg L, Ørskov AD, Liu M, Harsløf LBS, Jones PA, Grønbæk K. Gillberg L, et al. Semin Cancer Biol. 2018 Aug;51:59-67. doi: 10.1016/j.semcancer.2017.11.001. Epub 2017 Nov 2. Semin Cancer Biol. 2018. PMID: 29102482 Review.
Vitamin C deficiency is rare in the general population, but is frequently observed in patients with cancer. ...Additionally, several recent studies have renewed interest in the use of pharmacological doses of vitamin C injected intravenously to selecti
Vitamin C deficiency is rare in the general population, but is frequently observed in patients with cancer. ...Additionally, s
Vitamin C stabilizes CD8+ iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse.
Iamsawat S, Tian L, Daenthanasanmak A, Wu Y, Nguyen HD, Bastian D, Yu XZ. Iamsawat S, et al. Blood Adv. 2019 Dec 23;3(24):4187-4201. doi: 10.1182/bloodadvances.2019000531. Blood Adv. 2019. PMID: 31856270 Free PMC article.
CD4+ iTregs can effectively prevent GVHD but impair the graft-versus-leukemia (GVL) effect, whereas CD8+ iTregs preserve the GVL effect but have limited efficacy in GVHD control because of their instability under inflammatory conditions. Thus, we aimed to stabilize CD8+ iT …
CD4+ iTregs can effectively prevent GVHD but impair the graft-versus-leukemia (GVL) effect, whereas CD8+ iTregs preserve the GVL effe …
Vitamin C Inhibits Lipopolysaccharide-Induced Hyperinflammatory State of Chronic Myeloid Leukemia Cells through Purinergic Signaling and Autophagy.
Pires DA, Brandão-Rangel MAR, Silva-Reis A, Olímpio FRS, Aimbire F, Oliveira CR, Mateus-Silva JR, Zamarioli LS, Bachi ALL, Bella YF, Santos JMB, Bincoletto C, Lancha AH Jr, Vieira RP. Pires DA, et al. Nutrients. 2024 Jan 29;16(3):383. doi: 10.3390/nu16030383. Nutrients. 2024. PMID: 38337668 Free PMC article.

Furthermore, in LPS + CQ-stimulated cells, vitamin C at a concentration of 10 g/mL inhibited the expression of LC3-II (p < 0.05). Conversely, both doses of vitamin C led to the release of the anti-inflammatory cytokine interleukin-10 (IL-10) (5 g/mL

Furthermore, in LPS + CQ-stimulated cells, vitamin C at a concentration of 10 g/mL inhibited the expression of LC3-II (p < …
510 results